$234.53+8.59% · 3M
Moving avg
1W-1.24%
1M+10.91%
3M+10.57%
6M-5.56%
YTD-6.20%
1Y-4.72%
3Y+2.35%
5Y+5.66%
52-week range
$195.1453% of range$269.44
Company health
Value2/6
Growth5/6
Profitability5/6
Health5/6
Dividend5/6
Bull vs bear
Strengths
- Analysts see 16% upside to a $271 target
- Analyst consensus is "Buy"
- High return on equity (1105%)
- Revenue compounding 11% a year
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$22.86B
Enterprise value
$24.34B
P/E ratio (TTM)
29.29x
P/S ratio (TTM)
3.82x
EV/EBITDA
13.31x
Per share & returns
EPS (TTM)
$7.98
Dividend yield
1.08%
Beta (1Y)
0.91
30-day change
+10.91%
Trading
Volume (24h)
111.95K
Previous close
$236.60
Shares outstanding
97.46M
About STERIS plc
Sector
Healthcare
Industry
Medical - Specialties
Exchange
NYSE
Symbol
STE
STERIS plc is a large-cap healthcare company in the Medical - Specialties industry. Its shares are listed on NYSE under the ticker STE.
Frequently asked questions
What is STERIS plc's market cap?
STERIS plc (STE) has a market capitalization of $22.86B.
What is STERIS plc's P/E ratio?
STERIS plc trades at a price-to-earnings (P/E) ratio of 29.29.
What exchange does STE trade on?
STE trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.02-0.02%
$1.15T cap
Johnson & JohnsonJNJ
$261.21+0.13%
$629.49B cap
AbbVie Inc.ABBV
$250.31+0.62%
$442.25B cap
UnitedHealth Group IncorporatedUNH
$403.33-0.56%
$366.28B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.58+1.25%
$332.39B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap